title: Parenteral use of recombinant   activated factor VII during   diffuse alveolar hemorrhage   secondary to leptospirosis.
authors.forename: Alexis
authors.initials: A
authors.lastname: Tatopoulos
authors.forename: Delphine
authors.initials: D
authors.lastname: Herbain
authors.forename: Céline
authors.initials: C
authors.lastname: Kazmierczak
authors.forename: Pierre-Edouard
authors.initials: PE
authors.lastname: Bollaert
authors.forename: Sébastien
authors.initials: S
authors.lastname: Gibot
mesh_terms: D015942:Factor VIIa / Q000494:pharmacology / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007922:Leptospirosis / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011295:Prenatal Care; D011650:Pulmonary Alveoli / Q000503:physiopathology*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D015898:Tomography Scanners, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa